Home / Share Price Target / Marksans
Marksans Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Marksans Pharma Limited | |||
 | Symbol: MARKSANS | ||
| Price: ₹308.64 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—General | |||
Show Table of Contents
Table of Contents
- 1: Marksans Pharma Brief Company Overview
- 1.1: Marksans Pharma Limited: A Versatile Generic Pharmaceutical Giant
- 1.2: Marksans Pharma Financial Performance
- 1.2.1: Is Marksans Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Marksans Pharma Share Price Target For 2024
- 2.1.1: Marksans Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Marksans Pharma Share Price Prediction For 2024
- 2.2: Marksans Pharma Share Price Target For 2025
- 2.2.1: Marksans Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Marksans Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Marksans Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Marksans Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Marksans Pharma Past Performance
Marksans Pharma Brief Company Overview
Marksans Pharma Limited: A Versatile Generic Pharmaceutical Giant
Established in 1992, Marksans Pharma Limited is a leading pharmaceutical company renowned for its comprehensive product portfolio and global reach.
Diverse Product Range:
- Analgesics
- Antidiabetics
- Cardiovascular medications
- Antibiotics
- Dermatology products
- Hormonal therapies
- Injectables
- Gastroenterology formulations
Global Presence:
Headquartered in Mumbai, India, Marksans Pharma Limited markets its products worldwide.
Commitment to Quality:
The company is dedicated to providing high-quality, affordable generic medications to meet the evolving needs of patients globally.
Marksans Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 13,665.15 Crore | Market valuation of Marksans Pharma's shares. |
| Revenue (TTM) | 2,267.99 Crore | Total revenue generated by Marksans Pharma over the past twelve months. |
| Net Income (TTM) | +333.79 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 18.28% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 14.71% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +18.09% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +29.29% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 11.7 | Company's total debt divided by total shareholder equity. |
| Total Debt | 244.06 Crore | Sum of Marksans Pharma's current & long-term financial obligations. |
| Total Cash | 700.57 Crore | Total amount of liquid funds available to Marksans Pharma. |
| Beta | 1.66 | Beta is greater than 1 indicating that the Marksans Pharma's price is more volatile than the market. |
Is Marksans Pharma A Good Buy For Long Term?
No valid response content found
To predict the Marksans Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Marksans Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Marksans Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Marksans Pharma shares in 2024, see the table below.
Marksans Pharma Share Price Target Table For 2024
| Marksans Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 318.97 (+3.34%) | Custom Fibonacci Extension Lvl 82% |
| 2024 Target 2 | 314.84 (+2%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 311.43 (+0.9%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 308.64 | Marksans Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 307.45 (-0.39%) | Price Action: Chart |
| Stop Loss 2 | 303.55 (-1.65%) | Fibonacci Retracement Level 50% |
| Stop Loss 3 | 300.00 (-2.8%) | Price Action: 06 Nov 2024 High |
Summary: Marksans Pharma Share Price Prediction For 2024
In summary, Marksans Pharma has surged by ₹148.04, achieving a notable +91.89% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Marksans Pharma for 2024 predicts an additional rise of 0.9% to 3.34% by the end of 2024 with three potential targets T1: 311.43, T2: 314.84, T3: 318.97. Stop Loss at SL1: 307.45, SL2: 303.55, SL3: 300.00.
Marksans Pharma has a 52-week high of ₹328.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹130.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Marksans Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Marksans Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Marksans Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Marksans Pharma shares in 2025, see the table below.
Marksans Pharma Share Price Target Table For 2025
| Marksans Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 457.15 (+48.11%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 445.81 (+44.44%) | Price Action: Chart |
| 2025 Target 1 | 441.40 (+43.01%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 308.64 | Marksans Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 277.75 (-10.01%) | Price Action: Oct 2024 Low |
| Stop Loss 2 | 274.85 (-10.95%) | Price Action: 18 Oct 2024 Low |
| Stop Loss 3 | 271.35 (-12.09%) | Price Action: 21 Oct 2024 Low |
Summary: Marksans Pharma Share Price Prediction For 2025
In summary, Marksans Pharma has surged by ₹148.04, achieving a notable +91.89% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Marksans Pharma for 2025 predicts an additional rise of 43.01% to 48.11% by the end of 2025 with three potential targets T1: 441.40, T2: 445.81, T3: 457.15. Stop Loss at SL1: 277.75, SL2: 274.85, SL3: 271.35.
Marksans Pharma has a All-Time high of ₹328.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹130.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Marksans Pharma, we have created a specific page for that check here: Marksans Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Marksans Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Marksans Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 18.86% over the next 15 years.
For complete year by year Marksans Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Marksans Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Marksans Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹308.64 | [Current Price] |
| 2024 | ₹329.45 | 6.74% |
| 2025 | ₹619.66 | 88.08% |
| 2026 | ₹863.72 | 39.38% |
| 2027 | ₹1,197.15 | 38.6% |
| 2028 | ₹1,334.11 | 11.44% |
| 2029 | ₹1,522.54 | 14.12% |
| 2030 | ₹1,921.12 | 26.17% |
| 2031 | ₹2,141.17 | 11.45% |
| 2032 | ₹2,563.55 | 19.72% |
| 2033 | ₹2,573.85 | 0.4% |
| 2034 | ₹2,715.63 | 5.5% |
| 2035 | ₹3,222.57 | 18.66% |
| 2036 | ₹3,418.62 | 6.08% |
| 2037 | ₹3,929.96 | 14.95% |
| 2038 | ₹3,813.58 | -2.97% |
| 2039 | ₹3,702.68 | -2.91% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Marksans Pharma Past Performance
- In 1995, Marksans Pharma opening price was ₹3
- As of Fri 22 Nov 2024 the price stands at ₹308.64.
- This represents a Compound Annual Growth Rate (CAGR) of 16.7%.
- In 29 years, an investment of 10,000 would have become ₹10.28 Lakh.
As we wrap up, we hope you like our study on Marksans Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Marksans Pharma Share Price History
- Marksans Pharma Price Target Tomorrow
- Marksans Pharma Dividend History
- Marksans Pharma Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
